The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: The cardiovascular health study

American Journal of Kidney Diseases

Volumn 44, Issue 1, 2004, Pages 25-34

  Barzilay, Joshua I ^a   Peterson, Do ^b   Cushman, Mary ^b   Heckbert, Susan R ^b   Cao, Jie J ^b   Blaum, Caroline ^b   Tracy, Russell P ^b   Klein, Ronald ^b   Herrington, David M ^b  

^a KAISER PERMANENTE   (United States)

^b NONE

Author keywords

C reactive protein (CRP); cardiovascular disease (CVD) risk factors; Microalbuminuria; white blood cell (WBC) count

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

AGE; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIUM; FEMALE; FIBRINOGEN BLOOD LEVEL; GROUPS BY AGE; HUMAN; HUMAN CELL; HYPERTENSION; IN VIVO STUDY; ISCHEMIA; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MALE; MICROALBUMINURIA; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALBUMINURIA; BIOLOGICAL MARKERS; BRACHIAL ARTERY; COMORBIDITY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; SMOKING;

EID: 3042811123     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.03.022     Document Type: Article

References (42)

1. Lydakis C., Lip G.Y.H. Microalbuminuria and cardiovascular risk. Q J Med. 91:1998;381-391
2. Borch-Johnsen K., Feldt-Rasmussen B., Strandgaard S., Schroll M., Jensen J.S. Urinary albumin excretion. An independent risk factor for ischemic heart disease. Arterioscler Thromb Vasc Biol. 19:1999;1992-1997
3. Marso S.P., Ellis S.G., Tuzcu M., et al. The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics. J Am Coll Cardiol. 33:1999;1269-1277
4. Chen J., Gall M.A., Yokoyama H., Jensen J.S., Deckert M., Parving H.H. Raised sialic acid concentration in NIDDIABETES patients with and without nephropathy. Diabetes Care. 19:1996;130-134
5. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects The Insulin Resistance Atherosclerosis Study. Kidney Int. 58:2000;1703-1710
6. Kim Y.I., Kim C., Choi C.S., et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res Clin Pract. 52:2001;145-152
7. Mykkanen L., Zaccaro D.J., Wagenknecht L.E., Robbins D.C., Gabriel M., Haffner S.M. Microalbuminuria is associated with insulin resistance in nondiabetic subjects The Insulin Resistance Atherosclerotic Study. Diabetes. 47:1998;793-800
8. Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab. 26:(suppl 4):2000;S64-S66
9. Fioretto P., Stehouwer C.D., Mauer M., et al. Heterogeneous nature of microalbuminuria in NIDDIABETES Studies of endothelial function and renal structure. Diabetologia. 41:1998;233-236
10. Lim S.C., Caballero A.E., Smakowski P., LoGerfo F.W., Horton E.S., Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care. 22:1999;1865-1870
11. Meeking D.R., Cummings M.H., Thorne S., et al. Endothelial dysfunction in type 2 diabetic subjects with and without microalbuminuria. Diabet Med. 16:1999;841-847
12. Hirano T., Kashiwazaki K., Moritomo Y., Nagano S., Adachi M. Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDIABETES patients. Diabetes Res Clin Pract. 36:1997;11-18
13. Kario K., Matsuo T., Kobayashi H., et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol. 16:1996;455-461
14. Pedrinelli R., Giampitro O., Carmassi F., et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 344:1994;14-18
15. Romundstad S., Holmen J., Hallan H., Kvenild K., Kruger O., Mithjell K. Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. J Int Med. 252:2002;164-172. The Nord-Trondelag Health Study (HUNT, 1995-97), Norway
16. Winocour P.H., Harland J.O.E., Millar J.P., Laker M.F., Alberti K.G.M.M. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis. 93:1992;71-83
17. Jager A., Kostense P.J., Nijpels G., Heine R.J., Bouter L.M., Stehouwer C.D.A. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with insulin resistance syndrome The Hoorn Study. Diabetologia. 41:1998;694-700
18. Metcalf P., Baker J., Scott A., Wild C., Scragg R., Dryson E. Albuminuria in people at least 40 years old Effect of obesity, hypertension, and hyperlipidemia. Clin Chem. 38:1992;1802-1808
19. Fried L.P., Borhani N.O., Enright P., et al. The Cardiovascular Health Study Design and rationale. Ann Epidemiol. 1:1991;263-276
20. Cushman M., Cornell E.S., Howard P.R., Boville E.G., Tracy R.P. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 41:1995;264-270
21. Herrington D.M., Fan L., Drum M., et al. Brachial flow-mediated vasodilator responses in population-based research Methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk. 8:2001;319-328
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis Model Assessment Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419
23. Bonora E., Targher G., Alberiche M., et al. Homeostasis Model Assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 23:2000;57-63
24. Stehouwer C.D., Gall M.A., Twisk J.W., Knudsen E., Emeis J.J., Parving H.H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes Progressive, interrelated, and independently associated with risk of death. Diabetes. 51:2002;1157-1165
25. Klahr S. Mechanisms of progression of chronic renal damage. J Nephrol. 12:(suppl 2):1999;S53-S62
26. Pankow J.S., Folsom A.R., Cushman M., et al. Familial and genetic determinants of systemic markers of inflammation The NHLBI family heart study. Atherosclerosis. 154:2001;681-689
27. Vozarova B., Weyer C., Lindsay R.S., Pratley R.E., Bogardus C., Tataranni P.A. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 51:2000;455-461
28. Schmidt M.I., Duncan B.B., Sharrett A.R., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study) A cohort study. Lancet. 353:1999;1649-1652
29. Tong P.C., Lee K.F., So W.Y., et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care. 27:2004;216-222
30. Suematsu M., Suzuki H., Delano F.A., Schmid-Schonbein G.W. The inflammatory aspect of the microcirculation in hypertension Oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation. 9:2002;259-276
31. Lee C.D., Folsom A.R., Nieto F.J., Chambless L.E., Shahar E., Wolfe D.A. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and white men and women Atherosclerosis Risk in Communities Study. Am J Epidemiol. 154:2001;758-764
32. Mennen L.I., Balkau B., Royer B., et al. Microalbuminuria and markers of the atherosclerotic process The D.E.S.I.R study. Atherosclerosis. 154:2001;163-169
33. Asakawa H., Tokunaga K., Kawakami F. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J Diabetes Complications. 14:2000;121-126
34. Lechi C., Gaino S., Zuliani V., et al. Elevated plasma fibrinogen levels in patients with essential hypertension are related to vascular complications. Int Angiol. 22:2003;72-78
35. Agewall S., Lindstedt G., Fagerberg B. Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men. Atherosclerosis. 157:2001;197-202
36. Diercks G.F., Stroes E.S., van Boven A.J., et al. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects. Atherosclerosis. 163:2002;121-126
37. Lim S.C., Caballero A.E., Smakowski P., LoGerfo F.W., Horton E.S., Veves A. Soluble intercellular adhesion molecule, vascular adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care. 22:1999;1865-1870
38. Taddei S., Virdis A., Mattei P., et al. Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients. J Hypertens. 13:1995;1003-1008
39. Kario K., Matsuo T., Kobayashi H., et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol. 16:1996;455-461
40. Tabaei B.P., Al-Kassab A.S., Ilag L.L., Zawacki C.M., Herman W.H. Does microalbuminuria predict diabetic nephropathy? Diabetes Care. 24:2001;1560-1566
41. Garg A.X., Kiberd B.A., Clark W.F., Haynes R.B., Clase C.M. Albuminuria and renal insufficiency prevalence guides population screening Results from NHANES III. Kidney Int. 61:2002;2165-2175
42. Cushman M., Legault C., Barrett-Connor E., et al. Effect of postmenopausal hormones on inflammation-sensitive proteins The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation. 100:1999;717-722